Valuation Parnax Lab Limited

Stocks

Market Closed - Bombay S.E. 05:02:15 2026-11-08 EST			5-day change	1st Jan Change
110.00 ^INR	0.00%		+3.72%	-15.38%

08-14	Parnax Lab Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-28	Parnax Lab Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	165.8	1,120	597.9	1,488	1,229	1,476
Change	-	575.13%	-46.6%	148.81%	-17.39%	20.14%
Enterprise Value (EV) ¹	753	1,767	1,132	2,290	1,919	2,282
Change	-	134.62%	-35.91%	102.2%	-16.2%	18.92%
P/E	-45.6x	13.6x	6.69x	15.5x	10.7x	12.5x
PBR	0.51x	2.68x	0.96x	2.08x	1.48x	1.55x
PEG	-	-0x	-0.3x	2.08x	0.5x	5.58x
Capitalization / Revenue	0.18x	0.69x	0.36x	0.79x	0.65x	0.59x
EV / Revenue	0.84x	1.08x	0.68x	1.21x	1.02x	0.92x
EV / EBITDA	7.58x	7.76x	5.03x	10.1x	7.47x	7.87x
EV / EBIT	15.2x	10.2x	6.79x	13.6x	9.83x	10.3x
EV / FCF	-20.2x	-11.1x	25.6x	-8.82x	39.8x	-7.42x
FCF Yield	-4.95%	-9%	3.9%	-11.3%	2.51%	-13.5%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.428	9.684	7.786	8.366	10.03	10.25
Distribution rate	-	-	-	-	-	-
Net sales ¹	901.3	1,630	1,676	1,888	1,878	2,486
EBITDA ¹	99.3	227.8	225.2	227.8	256.9	290.1
EBIT ¹	49.53	172.5	166.7	167.8	195.1	220.9
Net income ¹	-3.64	82.43	86.18	96.09	115.2	117.8
Net Debt ¹	587.2	647.1	534.4	801.8	689.8	805.2
Reference price ²	19.50	131.65	52.06	129.53	107.00	128.55
Nbr of stocks (in thousands)	8,505	8,505	11,486	11,486	11,486	11,486
Announcement Date	9/7/21	9/6/22	9/6/23	9/5/24	9/6/25	9/7/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PARNAX LAB LIMITED	-	-	-	-	12.47M
ELI LILLY AND COMPANY	39.62x	13.42x	28.51x	0.5%	1,206B
JOHNSON & JOHNSON	40.43x	6.79x	19.09x	1.93%	665B
ABBVIE INC.	37.52x	8.51x	17.57x	2.38%	515B
ROCHE HOLDING AG	20.98x	5.12x	12.74x	2.57%	381B
MERCK & CO., INC.	97.18x	5.94x	25.33x	2.32%	362B
NOVARTIS AG	23.18x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.46x	4.89x	13.77x	1.79%	289B
AMGEN INC.	23.75x	7.3x	13.55x	2.19%	249B
GILEAD SCIENCES, INC.	-39.18x	7.28x	45.82x	1.98%	207B
Average	29.77x	7.24x	21.19x	2.04%	417.98B
Weighted average by Cap.	35.67x	8.55x	21.86x	1.73%